Morgan Stanley Cytek Biosciences, Inc. Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Cytek Biosciences, Inc. stock. As of the latest transaction made, Morgan Stanley holds 1,067,058 shares of CTKB stock, worth $7.28 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,067,058

Previous 894,364 19.31%

Holding current value

$7.28 Million

Previous $4.99 Million 18.46%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$4.73 - $6.73 $816,842 - $1.16 Million	172,694 Added 19.31%	1,067,058 $5.91 Million
Q2 2024 Oct 17, 2024	BUY	$5.3 - $6.91 $269,467 - $351,325	50,843 Added 6.03%	894,364 $4.99 Million
Q2 2024 Aug 14, 2024	BUY	$5.3 - $6.91 $269,467 - $351,325	50,843 Added 6.03%	894,364 $4.99 Million
Q1 2024 Oct 17, 2024	SELL	$6.29 - $9.15 $319,802 - $465,213	-50,843 Reduced 5.68%	843,521 $5.66 Million
Q1 2024 Aug 16, 2024	BUY	$6.29 - $9.15 $46,325 - $67,389	7,365 Added 0.88%	843,521 $5.66 Million
Q1 2024 May 15, 2024	BUY	$6.29 - $9.15 $46,325 - $67,389	7,365 Added 0.88%	843,521 $5.66 Million
Q4 2023 Aug 16, 2024	SELL	$4.1 - $9.51 $238,652 - $553,558	-58,208 Reduced 6.51%	836,156 $7.63 Million
Q4 2023 Feb 13, 2024	BUY	$4.1 - $9.51 $909,638 - $2.11 Million	221,863 Added 36.12%	836,156 $7.63 Million
Q3 2023 Nov 15, 2023	BUY	$5.52 - $9.5 $242,863 - $417,971	43,997 Added 7.71%	614,293 $3.39 Million
Q2 2023 Aug 14, 2023	BUY	$6.69 - $11.99 $356,791 - $639,450	53,332 Added 10.32%	570,296 $4.87 Million
Q1 2023 May 15, 2023	BUY	$8.44 - $13.47 $2.76 Million - $4.41 Million	327,379 Added 172.68%	516,964 $4.75 Million
Q4 2022 Feb 14, 2023	SELL	$9.71 - $15.86 $247,187 - $403,748	-25,457 Reduced 11.84%	189,585 $1.94 Million
Q3 2022 Nov 14, 2022	BUY	$10.96 - $15.45 $201,653 - $284,264	18,399 Added 9.36%	215,042 $3.17 Million
Q2 2022 Oct 27, 2022	BUY	$7.41 - $11.56 $583,581 - $910,419	78,756 Added 66.81%	196,643 $2.11 Million
Q2 2022 Aug 15, 2022	BUY	$7.41 - $11.56 $583,581 - $910,419	78,756 Added 66.81%	196,643 $2.11 Million
Q1 2022 Oct 27, 2022	SELL	$9.89 - $17.25 $778,896 - $1.36 Million	-78,756 Reduced 40.05%	117,887 $1.27 Million
Q1 2022 May 13, 2022	BUY	$9.89 - $17.25 $1.12 Million - $1.95 Million	112,808 Added 2221.07%	117,887 $1.27 Million
Q4 2021 Feb 14, 2022	SELL	$16.14 - $25.04 $578,393 - $897,333	-35,836 Reduced 87.59%	5,079 $82,000
Q3 2021 Nov 15, 2021	BUY	$17.52 - $27.93 $716,830 - $1.14 Million	40,915 New	40,915 $875,000

Others Institutions Holding CTKB

# of Institutions

133

Shares Held

71.6M

Call Options Held

400

Put Options Held

View Full List

About Cytek Biosciences, Inc.

Ticker CTKB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 134,627,008
Market Cap $918M
Description
Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers ...

More about CTKB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account